Contemporary management of prenatally diagnosed spina bifida aperta — an update by Kosinski, Przemyslaw et al.
637
RE VIE W PAPER /  OBSTE TRICS
Ginekologia Polska
2018, vol. 89, no. 11, 637–641
Copyright © 2018 Via Medica
ISSN 0017–0011
DOI: 10.5603/GP.a2018.0108
Corresponding author:
Mirosław Wielgos
1st Department of Obstetrics and Gynecology, Medical University of Warsaw 
Starynkiewicza St. 1/3, 02–015 Warsaw, Poland 
tel.: +48 22 583 03 01, fax: +48 22 583 03 02, e-mail: mwielgos@wum.edu.pl
Contemporary management of prenatally diagnosed  
spina bifida aperta — an update
Przemyslaw Kosinski1, Robert Brawura Biskupski Samaha1, Michal Lipa1, Miroslaw Wielgos1, 
Thomas Kohl2
11st Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland 
2German Center for Fetal Surgery & Minimally-Invasive Therapy (DZFT), University Hospital Mannheim (UMM), Germany
ABSTRACT
Spina bifida aperta is a relatively common congenital defect that occurs in the general population. Once the disorder has 
been diagnosed, a discussion, that can be emotionally-charged, ensues about whether to treat it prenatally or to only offer 
surgery postnatally. Given that there are good arguments for and against both options, it is of paramount importance to 
gain a good understanding of the major advantages and disadvantages of the various surgical approaches. The aim of our 
paper is to summarize current knowledge about spina bifida and the potential benefits of prenatal surgery.
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INTRODUCTION
Neural tube defects are the most common of all con-
genital central nervous system anomalies and are a com-
mon cause of chronic disability in the general population. 
Each year 300.000 babies worldwide are born with a neural 
tube defect [1]. The signs and symptoms associated with 
neural tube defects have been characterised in the “two-hit 
hypothesis”; in which the first “hit” is the embryological 
malformation itself and the second “hit” is the secondary 
damage caused by prolonged exposure of the neural tissue 
to the intra-amniotic milieu [2].
In general, neural tube defects can occur in two major 
forms: spina bifida aperta (SBA), where there is an open 
lesion on the spine, and spina bifida occulta, in which the 
lesion is closed. Approximately 80% of all neural tube defects 
are “open” with myelomeningocele, meningocele, encepha-
locele, and anencephaly being the most common forms. 
Of the open-lesion forms, myelomeningocele occurs 
due to failure of the neural tube to close in the first four 
weeks after conception and sometimes can be visualised 
by ultrasound, as a fluid-filled sac containing spinal cord 
tissue and nerves, as early as first trimester of pregnancy. 
The least differentiated form of SBA is myeloschisis where 
there is an incomplete closure of the primary neural plate 
which results in a cleft spinal cord where the edges are flush 
with the defect [3]. 
Spina bifida occulta, the closed-lesion form of neural 
tube defects, is where neural tissue is not exposed but cov-
ered by skin. This disorder may be recognized by dysplastic 
skin, or a tuft of hair, dimple, birthmark, lump, vestigial tail, 
as well as other forms of spinal dysraphism. The occulta 
malformation has a far better prognosis than spina bifida 
aperta, and therefore during prenatal diagnosis must be 
differentiated from the latter. 
The presence of SBA means that the neural tissue gets 
progressively damaged from incessant exposure to fetal 
stools, the amniotic fluid and mechanical factors over the 
course of gestation [4]. In general, the extent and severity 
of postnatal neurological deficits depend on the segmental 
level of the lesion. Functional motor levels correlate with 
anatomic lesions in around 39% of patients. Yet in more 
than half of patients who did not undergo fetal surgery 
the correlation is less optimistic then we assume because, 
although the anatomical level suggests a better prognosis, 
in reality the neurological outcome is worse as a result of 
the functional level being two levels higher than the ana-
tomical level [5].
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Wheelchair use can be anticipated in 90% of patients 
with a thoracic lesion, in 45% with a lumbar lesion and in 
17% with a sacral lesion [6].
Furthermore, SBA is usually associated with Chi-
ari-type-II-malformation and hydrocephalus. Chi-
ari-type-II-malformation is the downward displacement of 
the cerebellar vermis and brainstem into the cervical verte-
bral canal [7]. More than 80% of affected individuals require 
a ventriculoperitoneal (VP) shunt to divert cerebrospinal 
fluid from brain ventricles to decompress the hydrocepha-
lus. The VP shunting rate depends on the lesion level, where 
a higher shunting rate is needed for higher level lesions. 
In most SBA cases, bladder and bowel incontinence are 
also be observed. These deficiencies may require intermit-
tent bladder catheterization and enemas. It has been esti-
mated that more than 80% of young adults with spina bifida 
have social bladder continence and almost half of them have 
scoliosis. In some cases, recurrent urinary tract infections, 
vesicoureteral reflux, and upper urinary tract dilation occur. 
A study by Bowman et al. [8] that summarised a 25-
year period of follow-up of 71 SBA patients, found that at 
least 75% of SBA children can be expected to reach early 
adulthood. Surprisingly, and most likely in contrast to the 
expectations of most fetal-medicine specialists, 85% of the 
patients in the study were attending or had graduated from 
high school and/or college. 
In a recent cohort study by Borgstedt-Bakke et al., 
14 (7%) of 200 patients with spina bifida died in the first 
year of life; and most of these died in the first three months 
of life from pneumonia, meningitis, peritonitis, pyelonephri-
tis or sepsis [9].
From the above it becomes clear, that postnatal man-
agement of patients with neural tube defects is challenging 
and at best involves multiple disciplines to ensure the best 
possible outcome and quality of life for affected patients.
PRENATAL DIAGNOSIS 
In the 1980s the main method of screening for open 
spina bifida was by maternal serum α-fetoprotein at around 
16 weeks of gestation, and the method of diagnosis was 
amniocentesis and the measurement of amniotic fluid 
α-fetoprotein and acetyl cholinesterase. 
Nowadays, most cases of spina bifida aperta are di-
agnosed during routine second trimester anomaly scans 
at 20–22 weeks of gestation. The diagnosis is commonly 
achieved not by identification of the malformation itself 
but by the indirect cranial and cerebellar signs (respectively, 
the lemon and banana signs) first described by Nicolaides 
et al. [10].
Recently, even first trimester diagnosis is possible by 
sonographic assessing intracranial translucency and the 
posterior brain region [11]. It has even been suggested 
that this screening technique could be incorporated into 
routine fetal sonographic assessments at 11–13 weeks of 
gestation [12].
PRENATAL COUNSELLING
In many European countries, the current practice of 
patient counselling after the prenatal diagnosis of spina 
bifida includes offering the following treatment options: 
1. Pregnancy carried to term, then postnatal closure.
2. Fetal surgery.
3. Delivery at term and compassionate care.
4. Termination of pregnancy.
Given the grave consequences of SBA described in the 
literature and summarised above, the biggest risk to fetal 
survival is because of prenatal diagnosis of the disease. 
When confronted with the prognosis of lower limb paralysis, 
bladder and bowel malfunction, cerebral malformations and 
hydrocephalus, patients opt for termination at a high rate; 
for instance, the rate described in a large cohort of prena-
tally diagnosed cases in Germany was as high as 90% [13].
PRENATAL MANAGEMENT
The management options for patients with SBA babies 
that are carried to term have dramatically widened over 
the past three decades. Broadly speaking, there are now 
three possible therapeutic routes: postnatal repair, prenatal 
in-utero repair by open fetal surgery, and prenatal in-utero 
repair by minimally-invasive fetoscopy. 
Whereas postnatal surgery protects against infec-
tions and is often performed for cosmetic reasons, it has 
the disadvantage of being unable to restore the infant’s 
neurological functions that were lost in-utero. In contrast, 
fetal surgery results in improved neurological function in 
most cases because it prevents the further progression 
of the disease process during the final four months of 
gestation. The rationale for offering prenatal SBA repair 
was arrived at based on animal studies, which showed 
that prenatal coverage of the malformation preserves 
neurological function and can even reverse hindbrain 
herniation [14, 15].
Experience with open and minimally-invasive in utero 
surgeries in human subjects shows similar results, including 
a lower incidence of shunt-dependent hydrocephalus. It has 
to be stressed that despite the benefits of fetal SBA surgery, 
postnatally most patients will still exhibit neurological signs 
and symptoms. Yet these are ameliorated when compared 
with those exhibited by patients who were first operated 
on postnatally. A recent American College of Obstetricians 
and Gynecologists Committee Opinion states that patients 
with prenatally diagnosed SBA who meet the criteria for 
in-utero repair should, nevertheless, be offered all manage-
ment options [16].
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OPEN FETAL SURGERY FOR SPINA BIFIDA IN 
THE POST-MOMS ERA
During “open” SBA surgery, which means following ma-
ternal laparotomy and hysterotomy, the lesion may either 
be closed primarily with the aid of skin and muscle flaps or 
closed with a synthetic patch. 
Between 2003 and 2010, the prospective randomized 
trial known as the “Management of Myelomeningocele 
Study” (MOMS), sought to randomized 200 patients at three 
participating US fetal surgery centres, to compare the open 
surgical approach and the postnatal repair approach. The 
study considered two outcomes: the first, measured at 
12 months, was death or need for a ventricular shunt; and 
the second, measured at 30 months, was a composite score 
of standardized tests for mental and motor development. 
The trial was stopped after only 183 patients were rand-
omized and after 158 patients had undergone a planned 
interim analysis, which showed that there were statistically 
significant improved outcomes after prenatal spina bifida 
treatment [17]. Moreover, the proportion of infants in the 
study who showed no evidence of hindbrain herniation was 
higher in the prenatal surgery group (36%) compared with 
the postnatal surgery group (4%). These children from the 
prenatal repair group also had higher chances of walking 
without orthotics and had better motor function than those 
from the postnatal repair group. An improvement in func-
tional motor level by two or more levels was seen in 32% and 
by one or more levels in 11% of the prenatal surgery group, 
compared with 12% and 9% respectively, in the postnatal 
repair group [1].
Major complications related to prenatal surgery report-
ed in the MOMS trial were oligohydramnios, separation 
of membranes, membranes rupture and preterm delivery. 
During the study, in which both groups were delivered by 
Cesarean-section at approximately 37 weeks of pregnancy, 
only 64% of the patients had an intact and well-healed 
hysterectomy scar, and 10% had some form of uterine de-
hiscence [18]. 
Another study by Wilson et al., which analysed 34 pa-
tients after open prenatal spina bifida repair via hysteretomy, 
found 18% of patients had uterine rupture or dehiscence 
complications; and 3% of their patients required a hysterec-
tomy at the time of the caesarean section [19]. It was clear 
that there were two conflicting outcomes emerging: while 
prenatal surgery improved neonatal outcomes, because of 
the uterine entry via hysteretomy, it also increased maternal 
and obstetric risks. 
MINIMALLY-INVASIVE FETAL SURGERY FOR 
SBA
In order to minimize maternal injury from open fetal 
surgery, Brunner et al. and Kohl et al. pioneered mini-
mally-invasive surgery techniques for SBA [20]. Brunner’s 
minimally-invasive contribution was fetoscopic surgery, 
which he subsequently relinquished because it still re-
quired laparotomy and because there were technical dif-
ficulties and complications. However, Kohl et al. reported 
in 2006 a minimally-invasive fetoscopic approach wherein 
intraamniotic access is achieved entirely percutaneously by 
using three ports. Following partial removal of the amniotic 
fluid, the amniotic cavity is insufflated with CO2 to improve 
visualisation; and the placode is dissected free and covered 
with a collagen patch that is then sutured to the surround-
ing skin [21]. 
Even in Kohl’s first SBA patients, independent investiga-
tors found statistically better sensory and motor functions 
of the lower extremities as well as a lower shunt rate [22]. 
However, to date, the procedure is associated with a 15% 
percent risk of fetal demise, and it has met with harsh criti-
cism from some [23].
Following the development of a special protocol for 
achieving safe maternal and fetal anesthesia during feto-
scopic surgery for spina bifida [24], all the fetuses of a more 
recent cohort of 51 who were operated on by Kohl survived 
prenatal surgery [25]. The Neurological results of this group 
were similar to the earlier group of Kohl’s patients. Yet a high 
rate of premature rupture of the membranes (84%) that 
was seen following this approach, shows that further im-
provement of the technique is required. Fortunately, after 
fetoscopic surgery, about 90% of patients are born beyond 
the 30th week of gestation. To date, the risk of severe pre-
term complications has become much lower in the hands 
of experienced neonatologists. The mean gestational age at 
delivery stands at approximately 33 weeks [25, 26].
In 2016 Pedreira et al. published data on the initial results 
of a Brazilian study of minimally-invasive fetoscopic SBA 
repair [27]. Whereas the study’s technique for fetal access 
and amniotic insufflation was adopted from Kohl’s method, 
in contrast to his approach, Pedreira covered the dissected 
neural tissue with a biocellulose patch and closed the skin 
over the patch with a single running suture. Similar to Kohl’s 
experience, most of Pedreira’s patients benefitted by exhibit-
ing impressive neurological function and a low shunt-rate 
but they also experienced premature membrane ruptures 
and delivered at a mean gestational age of 32 weeks. 
Another approach described by Belfort et al., is surgery 
via laparotomy and exteriorization of the uterus [28]. Their 
approach makes it possible to plicate the membranes to the 
uterine wall by transuterine-transmembrane stay sutures 
before placing the trocars into the amniotic cavity. Further-
more, the insufflation gas was humidified and warmed to 
further potentially decrease any damage to the chorioam-
niotic membranes. The dissected placode was then sutured 
(including skin and dura) by a running suture. Following 
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this approach, the authors reported similar neurological 
benefits to Kohl and Pedreira, and they also reported a much 
lower rate of premature rupture of membranes (23%). Most 
encouragingly in their study, the mean gestational age at 
delivery reached 38 weeks [29].
SUMMARY
Fetal SBA surgery is a rapidly advancing field as it holds 
out the promise of improving bladder, bowel and lower limb 
functions and of reducing the need of hydrocephalus shunt-
ing in most prenatally operated fetuses. The major concern 
of open fetal surgery for SBA stems from the marked ma-
ternal trauma from laparotomy and hysterotomy. In MOMS 
patients, a uterine dehiscence rate of 12.5% was reported. 
Yet in more recent studies of patients, this rate has been 
lowered by technical modifications [30].
In contrast to open repair, minimally-invasive techniques 
limit maternal injury and avoid both laparotomies and hys-
terotomies. Consequently, following all of the fetoscopic ap-
proaches used, uterine dehiscence remains absent. Because 
all fetoscopic procedures provide a simpler coverage of the 
neural tissue than their open counterpart, which promotes 
closure of the lesion by several layers, there seems to be 
less iatrogenic damage to the neural tissue from fetoscopic 
surgery [31].
However, further technical improvements are desired 
in the fully percutaneous approaches with the goal of 
decreasing the still too-high rate of premature rupture of 
membranes and to prolong pregnancy. In this respect, the 
experience of Belfort et al. provides a way forward. 
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